Evidence method
Level · gp.fundamentals.debt_to_revenue
188.73% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
PCRX · Jun 30, 2026
Pacira BioSciences, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001628280-26-052635General Corporate
Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.69% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
29.86% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Yoy · gp.fundamentals.revenue
6.24% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
69.95% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.gross_margin
77.05% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
2.22% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
15.72% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
7.77% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History8 statesHistory building
Period transition
What moved in the state?
- Previous
- 207.27%
- Current
- 188.73%
- Delta
- -18.54%
- Previous
- 1.54%
- Current
- 0.69%
- Delta
- -0.84%
- Previous
- 14.48%
- Current
- 29.86%
- Delta
- 15.39%
- Previous
- 5.00%
- Current
- 6.24%
- Delta
- 1.24%
- Previous
- 84.77%
- Current
- 69.95%
- Delta
- -14.83%
- Previous
- 79.47%
- Current
- 77.05%
- Delta
- -2.43%
- Previous
- 3.89%
- Current
- 2.22%
- Delta
- -1.67%
- Previous
- 15.83%
- Current
- 15.72%
- Delta
- -0.11%
- Previous
- 7.63%
- Current
- 7.77%
- Delta
- 0.14%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Compared To · Pharmaceutical Preparations peers →Transitioned To · PCRX Fundamental State →Transitioned To · PCRX BALANCE_SHEET_LEVERAGE_DECREASED →Transitioned To · PCRX CAPEX_INTENSITY_DECREASED →Transitioned To · PCRX CASH_GENERATION_INCREASED →Transitioned To · PCRX GROWTH_INCREASED →Transitioned To · PCRX INVENTORY_PRESSURE_DECREASED →Transitioned To · PCRX MARGIN_DECREASED →Transitioned To · PCRX PROFITABILITY_DECREASED →Transitioned To · PCRX R_AND_D_INTENSITY_DECREASED →Transitioned To · PCRX SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.